HPR99 Does HTA Undermine the Goals of EMA Authorization Pathways? Time to Availability of Drugs Licensed Under Conditional Marketing Authorization Compared to Standard Marketing Authorization
Abstract
Authors
V Ardito J Robinson O Ciani